Blog
Deufol SE: Results for the first half of 2022
Deufol SE: Results for the first half of 2022
Sistema PJSFC: Sistema announces financial results for the second quarter 2022
Sistema PJSFC: Sistema announces financial results for the second quarter 2022
Affluent Medical : Affluent Medical announces the launch of a capital increase with preferential subscription rights (PSR)
Affluent Medical : Affluent Medical announces the launch of a capital increase with preferential subscription rights (PSR)
DGAP-News: European Commission approves FYB201/Ranivisio®1 (Ranivisio - Ranibizumab), a biosimilar to Lucentis®2
DGAP-News: European Commission approves FYB201/Ranivisio®1 (Ranivisio - Ranibizumab), a biosimilar to Lucentis®2
Cairn Homes Plc: Transaction in Own Shares
Cairn Homes Plc: Transaction in Own Shares
DGAP-News: Steinhoff International Holdings N.V. : Unaudited Trading Update for the nine-months ended 30 June 2022
DGAP-News: Steinhoff International Holdings N.V. : Unaudited Trading Update for the nine-months ended 30 June 2022
DGAP-News: BRAIN Biotech AG: On Track to Reach Financial Year 2021/22 Targets, 9M Reporting
DGAP-News: BRAIN Biotech AG: On Track to Reach Financial Year 2021/22 Targets, 9M Reporting
Kinarus Therapeutics initiates KIN001 Phase II KINFAST clinical trial in COVID-19 outpatients
Kinarus Therapeutics initiates KIN001 Phase II KINFAST clinical trial in COVID-19 outpatients
Markus Heusser proposed for election as Chairman of the Board of Directors and successor to Urs Kaufmann
Markus Heusser proposed for election as Chairman of the Board of Directors and successor to Urs Kaufmann
Rights and Issues Investment Trust PLC: Transaction in Own Shares
Rights and Issues Investment Trust PLC: Transaction in Own Shares
DGAP-Adhoc: Formycon announces EU-Approval of FYB201/Ranivisio®1 a biosimilar to Lucentis®2
DGAP-Adhoc: Formycon announces EU-Approval of FYB201/Ranivisio®1 a biosimilar to Lucentis®2
Form 8.3 - The Vanguard Group, Inc.: Tullow Oil plc
Form 8.3 - The Vanguard Group, Inc.: Tullow Oil plc
Form 8.3 - The Vanguard Group, Inc.: Schneider Electric SE
Form 8.3 - The Vanguard Group, Inc.: Schneider Electric SE
Form 8.3 - The Vanguard Group, Inc.: Shaftesbury plc
Form 8.3 - The Vanguard Group, Inc.: Shaftesbury plc
Form 8.3 - The Vanguard Group, Inc.: Meggitt plc
Form 8.3 - The Vanguard Group, Inc.: Meggitt plc
Form 8.3 - The Vanguard Group, Inc.: NortonLifeLock Inc.
Form 8.3 - The Vanguard Group, Inc.: NortonLifeLock Inc.
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: HomeServe plc
Form 8.3 - The Vanguard Group, Inc.: HomeServe plc
Form 8.3 - The Vanguard Group, Inc.: Euromoney Institutional Investor plc
Form 8.3 - The Vanguard Group, Inc.: Euromoney Institutional Investor plc
Form 8.3 - The Vanguard Group, Inc.: Darktrace plc
Form 8.3 - The Vanguard Group, Inc.: Darktrace plc
Form 8.3 - The Vanguard Group, Inc.: Capricorn Energy plc
Form 8.3 - The Vanguard Group, Inc.: Capricorn Energy plc
Form 8.3 - The Vanguard Group, Inc.: Brewin Dolphin Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Brewin Dolphin Holdings plc
Form 8.3 - The Vanguard Group, Inc.: AVEVA Group plc
Form 8.3 - The Vanguard Group, Inc.: AVEVA Group plc
Form 8.3 - The Vanguard Group, Inc.: Avast plc
Form 8.3 - The Vanguard Group, Inc.: Avast plc
DGAP-News: artnet AG: Artnet Shareholder Meeting highlights Robust Results and Innovation
DGAP-News: artnet AG: Artnet Shareholder Meeting highlights Robust Results and Innovation


